Invenomic Capital Management LP Sells 500,687 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Invenomic Capital Management LP lowered its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 34.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 973,650 shares of the health services provider's stock after selling 500,687 shares during the quarter. Invenomic Capital Management LP owned 0.57% of Teladoc Health worth $8,850,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Whipplewood Advisors LLC purchased a new position in shares of Teladoc Health in the fourth quarter worth $29,000. Lindbrook Capital LLC increased its position in shares of Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after acquiring an additional 1,612 shares during the period. Sterling Capital Management LLC raised its stake in shares of Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after acquiring an additional 4,101 shares during the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Teladoc Health during the fourth quarter worth about $60,000. Finally, Generali Investments Management Co LLC purchased a new position in Teladoc Health during the 4th quarter valued at about $64,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Trading Up 0.6 %

NYSE TDOC opened at $7.12 on Friday. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock's fifty day moving average price is $7.75 and its 200-day moving average price is $9.41. The stock has a market cap of $1.25 billion, a P/E ratio of -1.23 and a beta of 1.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.58% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

TDOC has been the subject of several research analyst reports. Evercore ISI dropped their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a report on Thursday, May 1st. Stifel Nicolaus dropped their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Piper Sandler reduced their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Bank of America dropped their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a research report on Friday, April 11th. Finally, Jefferies Financial Group reduced their price target on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $9.71.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.